As the functional mushroom market explodes, a new platform is exposing the gap between marketing hype and actual lab results — and changing how consumers buy adaptogens.

For the second quarter, CoreWeave projected revenue of $2.45 billion to $2.6 billion. The midpoint of that range fell below ...

Jim Cramer is not chasing it. And on May 7, he said exactly why. A caller on CNBC’s “Mad Money” Lightning Round asked Cramer ...

Wells Fargo analyst Michael Turrin raised his price target on CoreWeave to $155 from $135 on May 8, maintaining an Overweight ...

RBC Capital Markets bumped its 12-month target for the S&P 500 to 7,900 from 7,750, as stocks continue to notch fresh highs, according to TheFly. The firm joins a growing list of Wall Street outlets ...

The final pillar of Fidelity’s playbook focuses on “asset location,” the practice of matching investments to the accounts ...

U.S. banks push back on new CLARITY Act proposal, warning stablecoin rules may not fully protect deposits or limit risks.

The oldest bank of the United States raised its stake in Strategy Inc (NASDAQ: MSTR) in the first quarter of 2026 to almost a ...

Tapping into this demand, LOT Polish Airlines just launched its first direct flight between Warsaw and San Francisco. A ...

Year to date, Strategy has added 145,834 BTC worth approximately $11 billion, with much of the buying happening while Bitcoin ...

A deadly outbreak on a cruise ship stranded off Cape Verde has killed three people, infected eight, and triggered a global ...

Veteran investor Cathie Wood is enthusiastic about tech tycoon Elon Musk 's SpaceX making Wall Street debut, and is extremely ...